Impact of Obesity on Plasma Natriuretic Peptide Levels

Wang, Thomas J., Larson, Martin G., Levy, Daniel, Benjamin, Emelia J., Leip, Eric P., Wilson, Peter W.F., Vasan, Ramachandran S.·2004·Circulation

Cited by (1,000)

Items 301–400 of 1,000

  1. Paracrine cross-talk between skeletal muscle and macrophages in exercise by PGC-1α-controlled BNP
    Regula Furrer, Petra S. Eisele, Alexander Schmidt, Markus Beer, Christoph Handschin · 2017 · Scientific Reports
  2. Cardiovascular and metabolic effects of natriuretic peptides
    Cédric Moro, M Berlan · 2005 · Fundamental and Clinical Pharmacology
  3. Transcriptional control of human adipose tissue blood flow
    Perez‐Matute, Patricia, Neville, Matthew J., Tan, Garry D., Frayn, Keith N., Karpe, Fredrik · 2009 · Obesity
  4. Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome
    Yuanyuan Bao, Xiliang Shang, Linuo Zhou, Renming Hu, Yiming Li, Wei Qun Ding · 2011 · Archives of Medical Science
  5. Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: The cardiovascular health study
    Erika F. Brutsaert, Mary Lou Biggs, Joseph A. Delaney, Luc Djoussé, John S. Gottdiener, Joachim H. Ix, Francis Kim, Kenneth Jay Mukamal, David S. Siscovick, Russell P. Tracy et al. · 2016 · Metabolism
  6. A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA)
    Valentina Cannone, Christopher G. Scott, Paul A. Decker, Nicholas Bradley Larson, Walter Palmas, Kent D. Taylor, Thomas J. Wang, Deepak K. Gupta, Suzette J. Bielinski, John C. Jr Burnett · 2017 · PLoS ONE
  7. Usefulness of Adjusting for Clinical Covariates to Improve the Ability of B-Type Natriuretic Peptide to Distinguish Cardiac from Noncardiac Dyspnea
    Robert Kevin Rogers, Gregory J. Stoddard, Tom Greene, Andrew D. Michaels, Genaro Fernandez, Andrew Freeman, John W. Nord, Josef Stehlik · 2009 · The American Journal of Cardiology
  8. N-Terminal Pro-B-Type Natriuretic Peptide as an Indicator of Possible Cardiovascular Disease in Severely Obese Individuals: Comparison with Patients in Different Stages of Heart Failure
    K. M. Hermann-Arnhof, Ursula Hanusch‐Enserer, Thomas Kaestenbauer, Thomas Publig, Attila Dunky, Harald Rosén, Rudolf Prager, Ursula Köller · 2004 · Clinical Chemistry
  9. Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity
    Kistorp, Caroline, Bliddal, Henning, Goetze, Jens P, Christensen, Robin, Faber, Jens · 2014 · BMC Obesity
  10. Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales
    Albin Oh, Ross A. Okazaki, Flora Sam, María Valero‐Muñoz · 2019 · Frontiers in Cardiovascular Medicine
  11. Accumulation of natriuretic peptides is associated with protein energy wasting and activation of browning in white adipose tissue in chronic kidney disease
    Mathilde Luce, Christophe Barba, Dan Yi, Anne Mey, Damien Roussel, Émilie Bres, Bérengère Benoit, Myriam Pastural, Samuel Granjon, Jean Christophe Szelag et al. · 2020 · Kidney International
  12. Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals
    Vibhu Parcha, Nirav Patel, Orlando M. Gutiérrez, Peng Li, Karen L. Gamble, Kiran Musunuru, Kenneth B. Margulies, Thomas P. Cappola, Thomas J. Wang, Garima Arora et al. · 2021 · Journal of the American College of Cardiology
  13. Roux-en-Y gastric bypass alleviates hypertension and is associated with an increase in mid-regional pro-atrial natriuretic peptide in morbid obese patients
    Peter K. Bonfils, Mustafa Taskiran, Morten Damgaard, Jens Peter Goetze, Andrea Karen Floyd, Peter M Funch-Jensen, Viggo Bjerregaard Kristiansen, Mikael Støckel, Pierre Nourdine Bouchelouche, Niels Gadsbøll · 2015 · Journal of Hypertension
  14. N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction
    Justin Adrian Ezekowitz, Pierre Théroux, Wei-Ching Chang, Kenneth W. Mahaffey, Christopher Bull Granger, W. Douglas Weaver, Judith S. Hochman, Paul W. Armstrong · 2006 · Canadian Journal of Cardiology
  15. B-Type Natriuretic Peptides Improve Cardiovascular Disease Risk Prediction in a Cohort of Women
    Brendan M. Everett, Jeffrey S. Berger, JoAnn E. Manson, Paul M. Ridker, Nancy R. Cook · 2014 · Journal of the American College of Cardiology
  16. Lipid mobilization in subcutaneous adipose tissue during exercise in lean and obese humans. Roles of insulin and natriuretic peptides
    Katrien Koppo, Dominique Larrouy, Marie-Adeline Marqués, M Berlan, Magda Bajzová, Jan Polak, Johan Van de Voorde, Jens Bülow, Max Lafontan, F. Crampes et al. · 2010 · American Journal of Physiology-Endocrinology and Metabolism
  17. Association of Parental Obesity With Concentrations of Select Systemic Biomarkers in Nonobese Offspring
    Wolfgang Lieb, Michael J. Pencina, Katherine J. Lanier, Geoffrey H. Tofler, Daniel A Levy, Caroline S. Fox, Thomas J. Wang, Ralph B. D’Agostino, Ramachandran Srini Vasan · 2008 · Diabetes
  18. Obesity, Brain Natriuretic Peptide Levels and Mortality in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Systolic Function
    Stavros Stavrakis, Aneesh Venkat Pakala, Udho Thadani, J. Thomas, Muhammad Qasim Chaudhry · 2013 · The American Journal of the Medical Sciences
  19. Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction
    Luc Lorgis, Yves Cottin, Nicolas Danchin, Laurent Mock, Pierre Sicard, Philippe Buffet, Isabelle L’Huillier, Carole Richard, Jean‐Claude Beer, Claude Touzery et al. · 2011 · Heart
  20. Range of adiposity and cardiorenal syndrome
    Fernando Pazos · 2020 · World Journal of Diabetes
  21. Combining tissue Doppler echocardiography and B-type natriuretic peptide in the evaluation of left ventricular filling pressures: Review of the literature and clinical recommendations
    Hisham Dokainish · 2007 · Canadian Journal of Cardiology
  22. Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin
    Abigail May, Thomas J. Wang · 2007 · Expert Review of Molecular Diagnostics
  23. BNP in Overweight and Obese Patients With Heart Failure: An Analysis Based on the BNP-LV Diastolic Wall Stress Relationship
    Yoshitaka Iwanaga, Yasuki Kihara, Shinichiro Niizuma, Teruo Noguchi, Hiroshi Nonogi, Toru Kita, Yoichi Goto · 2007 · Journal of Cardiac Failure
  24. Prospective Associations of B-Type Natriuretic Peptide With Markers of Left Ventricular Function in Individuals With and Without Type 2 Diabetes
    Maria H. Kroon, Katja van den Hurk, Marjan Alssema, Otto Kamp B, Coen D.A. Stehouwer, Ronald M.A. Henry, Michaëla Diamant, Frans Boomsma, Giel Nijpels, Walter J. Paulus et al. · 2012 · Diabetes Care
  25. The heart in obesity-hypertension
    Stephen A Morse, Paco Eduardo Bravo, Malika C Morse, Efrain Reisin · 2005 · Expert Review of Cardiovascular Therapy
  26. Direct Comparison of Transcardiac Difference Between Brain Natriuretic Peptide (BNP) and N-Terminal Pro-BNP in Patients with Chronic Heart Failure
    Takayoshi Tsutamoto, Hiroshi Sakai, Chitose Ishikawa, Masanori Fujii, Toshinari Tanaka, Takashi Yamamoto, Hiroyuki Takashima, Masato Ohnishi, Atsuyuki Wada, Minoru Horie · 2007 · European Journal of Heart Failure
  27. B-Type Natriuretic Peptide Testing for Structural Heart Disease Screening: A General Population-Based Study
    Motoyuki Nakamura, Fumitaka Tanaka, Kenyu Sato, Toshie Segawa, Masahide Nagano · 2005 · Journal of Cardiac Failure
  28. Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF
    Maximilian Trum, Johannes Riechel, Elisa Schollmeier, Simon Lebek, Philipp Hegner, Kathrin Reuthner, Silvia Heers, Karoline Keller, Michael Wester, Susanne Klatt et al. · 2024 · Cardiovascular Research
  29. Insulin Resistance is Associated with Increased Concentrations of NT-proBNP in Rheumatoid Arthritis: IL-6 as a Potential Mediator
    William S. Bradham, Michelle J. Ormseth, Annette M. Oeser, Joseph F. Solus, Tebeb S. Gebretsadik, Ayumi Shintani, Christoph Stein · 2014 · Inflammation
  30. Association between serum soluble corin and obesity in C hinese adults: A cross‐sectional study
    Hao Yang Peng, Qiu Zhang, Hengshan Shen, Yan Liu, Xiangqin Chao, Honggang Tian, Xiaoqin Cai, Jianhua Jin · 2015 · Obesity
  31. Facing Morbid Obesity
    Maria Anastasia Ricci, Stefano DE VUONO, Matteo Scavizzi, Alessandra Gentili, Graziana Lupattelli · 2015 · Angiology
  32. The Conundrum of Patients with Obesity, Exercise Intolerance, Elevated Ventricular Filling Pressures and a Measured Ejection Fraction in the Normal Range
    Milton Packer · 2018 · European Journal of Heart Failure
  33. Emerging concepts of receptor endocytosis and concurrent intracellular signaling: Mechanisms of guanylyl cyclase/natriuretic peptide receptor-A activation and trafficking
    Indra Mani, Kailash N. Pandey · 2019 · Cellular Signalling
  34. The Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk With the Myocardium
    Valmore Bermúdez, Pablo Durán, Edward Rojas, Maria Paula Diaz, José Rivas, Manuel Nava, Maricarmen Chacín, Mayela Cabrera de Bravo, Rubén Carrasquero, Clímaco Cano Ponce et al. · 2021 · Frontiers in Endocrinology
  35. Biomarkers of cardiovascular stress in obstructive sleep apnea
    Micha Tobias Maeder, Christian Eugen Mueller, Otto Dagobert Schoch, Peter Ammann, Hans Rickli · 2016 · Clinica Chimica Acta
  36. Amount or Intensity? Potential Targets of Exercise Interventions in Patients with Heart Failure with Preserved Ejection Fraction
    Anna Feuerstein, Inke Bartels, Marlene Münch, Tobias Daniel Trippel, Ruhdja Lindhorst, Kathleen Nolte, Christoph Herrmann‐Lingen, Martin Halle, André Duvinage, Hans‐Dirk Düngen et al. · 2017 · ESC Heart Failure
  37. Natriuretic peptide receptor C contributes to disproportionate right ventricular hypertrophy in a rodent model of obesity‐induced heart failure with preserved ejection fraction with pulmonary hypertension
    Vineet Agrawal, Niki L. Fortune, Sheeline Yu, Julio L. Fuentes, Fubiao Shi, David S. Nichols, Linda A. Gleaves, Emily Poovey, Thomas J. Wang, Evan L. Brittain et al. · 2019 · Pulmonary Circulation
  38. Plasma Adiponectin Is Associated with Plasma Brain Natriuretic Peptide and Cardiac Function in Healthy Subjects
    Takahiro Ohara, Jiyoong Kim, Masanori Asakura, Hiroshi Asanuma, Satoshi Nakatani, Kazuhiko Hashimura, Hideaki Kanzaki, Tohru Funahashi, Hitonobu Tomoike, Masafumi Kitakaze · 2008 · Hypertension Research
  39. Clinical relevance of non-cardiac determinants of natriuretic peptide levels
    Claudio Passino, Roberta Poletti, Marianna Fontana, Giuseppe Vergaro, Concetta Prontera, Alessandra Gabutti, Alberto Giannoni, Michele Emdin, Aldo Clerico · 2008 · Clinical Chemistry and Laboratory Medicine (CCLM)
  40. The impact of an inverse correlation between plasma B-type natriuretic peptide levels and insulin resistance on the diabetic condition in patients with heart failure
    Yasunori Inoue, Makoto Kawai, Kosuke Minai, Kazuo Ogawa, Tomohisa Nagoshi, Takayuki Ogawa, Michihiro Yoshimura · 2015 · Metabolism
  41. Diagnostic and prognostic value of brain natriuretic peptide (BNP) concentrations in very elderly heart disease patients: Specific geriatric cut-off and impacts of age, gender, renal dysfunction, and nutritional status
    F. Blondé-Cynober, Gilles Morineau, B. Estrugo, E. Fillie, Christian Aussel, J.-P. Vincent · 2010 · Archives of Gerontology and Geriatrics
  42. The association between daily physical activity and plasma B-type natriuretic peptide in patients with glucose intolerance: a cross-sectional study
    Hidetaka Hamasaki, Hidekatsu Yanai, Masafumi Kakei, Mitsuhiko Noda, Osamu Ezaki · 2015 · BMJ Open
  43. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model
    Maria Pufulete, Rachel Maishman, Lucy Dabner, Syed Mohiuddin, William Hollingworth, Chris A. Rogers, Julian P. T. Higgins, Mark Dayer, John Macleod, Sarah Purdy et al. · 2017 · Health Technology Assessment
  44. Beneficial Effects of the Ketogenic Diet in Metabolic Syndrome: A Systematic Review
    Anouk Charlot, Joffrey Zoll · 2022 · Diabetology
  45. Obesity and heart failure with preserved ejection fraction: A growing problem
    Stuart B. Prenner, Paul J. Mather · 2017 · Trends in Cardiovascular Medicine
  46. Body Mass Index and B-Lines on Lung Ultrasonography in Chronic and Acute Heart Failure
    Philip Brainin, Brian Lee Claggett, Eldrin Foster Lewis, Kristin H. Dwyer, Allison A. Merz, Montane B Silverman, Varsha Swamy, Tor Biering‐Sørensen, Jose Rivero, Susan C. Cheng et al. · 2020 · ESC Heart Failure
  47. Renal Dysfunction Is a Confounder for Plasma Natriuretic Peptides in Detecting Heart Dysfunction in Uremic and Idiopathic Dilated Cardiomyopathies
    Marta Codognotto, Antonio Piccoli, Martina Zaninotto, Monica Maria Mion, Mario Plebani, Ugo Vertolli, Francesco Tona, Luisa Ruzza, Agata Barchitta, Giovanni Boffa · 2007 · Clinical Chemistry
  48. Slightly Elevated B-Type Natriuretic Peptide Levels in a Non-Heart Failure Range Indicate a Worse Left Ventricular Diastolic Function in Individuals with, as Compared with Individuals without, Type 2 Diabetes: The Hoorn Study
    Katja van den Hurk, Marjan Alssema, Otto Kamp B, Ronald M.A. Henry, Coen D.A. Stehouwer, Michaëla Diamant, Frans Boomsma, R.J. Heine, Giel Nijpels, Walter J. Paulus et al. · 2010 · European Journal of Heart Failure
  49. Foundation/American Heart Association Task Force on Practice Guidelines Heart Failure in Adults. A Report of the American College of Cardiology Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of
    Théodore G. Ganiats, Marvin A. Konstam, DONNA M. MANCINI, William T. Abraham, Donald E. Casey, Arthur Michael Feldman, Gary S. Ma · 2009
  50. The effect of GLP-1 receptor agonists on N-terminal pro-brain natriuretic peptide. A scoping review and metanalysis
    Angelo Avogaro, Danila Azzolina, Darío Gregori, Saula de Kreutzenberg, Gian Paolo Fadini, Edoardo Mannucci · 2022 · International Journal of Cardiology
  51. A State of Natriuretic Peptide Deficiency
    Michael Nyberg, Dijana Terzic, Trine Pagh Ludvigsen, Peter Mark, Natasha Barascuk Michaelsen, Steen Zabell Abildstrom, Mads D.M. Engelmann, Mark Richards, Jens Peter Goetze · 2022 · Endocrine Reviews
  52. N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea
    Micha Tobias Maeder, Peter Ammann, Hans Rickli, Otto Dagobert Schoch, Wolfgang C. Korte, Christoph Hürny, JONATHAN N. MYERS, Thomas Münzer · 2007 · Sleep And Breathing
  53. Natriuretic peptides in heart failure
    Jan Krupička, Tomáš Janota, J Hradec · 2013 · Cor et Vasa
  54. Clinical application of the natriuretic peptides in heart failure
    Horng H. Chen, John C. Jr Burnett · 2006 · European Heart Journal Supplements
  55. Plasma levels of atrial and brain natriuretic peptides in apparently healthy subjects: Effects of sex, age, and hemoglobin concentration
    Mareomi Hamada, Yuji Shigematsu, Masayuki Takezaki, Shuntaro Ikeda, Akiyoshi Ogimoto · 2016 · International Journal of Cardiology
  56. Les peptides natriurétiques : Une nouvelle voie de régulation de la lipolyse chez l’homme
    Coralie Sengenès, Cédric Moro, Jean Galitzky, M Berlan, Max Lafontan · 2005 · médecine/sciences
  57. Non-Cardiac Determinants of NT-proBNP Levels in the Elderly: Relevance of Haematocrit and Hepatic Steatosis
    Antonio Muscari, Annalisa Berzigotti, Giampaolo P. Bianchi, Claudia Giannoni, Amedeo Ligabue, Donatella Magalotti, Dario Sbano, Annalisa Zacchini, Marco Zoli · 2005 · European Journal of Heart Failure
  58. Novel biomarkers for heart failure
    Navaid Iqbal, Khwaja Sami Alim, Hermineh Aramin, Fatima Iqbal, Erik Green, Erin Higginbotham, Alan S. Maisel · 2013 · Expert Review of Cardiovascular Therapy
  59. Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program
    Geoffrey A. Walford, Yong Ma, Costas A. Christophi, Ronald B Goldberg, Petr Jarolı́m, Edward S. Horton, Kieren J. Mather, Elizabeth L. Barrett-Connor, Jaclyn Davis, José C. Florez et al. · 2014 · Diabetologia
  60. Brain Natriuretic Peptide and Body Fluid Composition in Patients with Chronic Kidney Disease: A Cross-Sectional Study to Evaluate the Relationship between Volume Overload and Malnutrition
    Yasushi Ohashi, Akinobu Saito, Keisuke Yamazaki, Reibin Tai, Tatsuru Matsukiyo, Atsushi Aikawa, Ken Sakai · 2016 · Cardiorenal Medicine
  61. Renal Clearance of N-Terminal pro-Brain Natriuretic Peptide Is Markedly Decreased in Chronic Kidney Disease
    Takayoshi Tsutamoto, Hiroshi Sakai, Takashi Yamamoto, Yoshihisa Nakagawa · 2019 · Circulation Reports
  62. Insulin receptor substrates differentially exacerbate insulin-mediated left ventricular remodeling
    Christian Riehle, Eric Thomas Weatherford, Adam R. Wende, Bharat Prasad Jaishy, Alec Seei, Nicholas S. McCarty, Monika Rech, Qian Shi, Gopireddy Raghavender Reddy, William J. Kutschke et al. · 2020 · JCI Insight
  63. Natriuretic Peptide Deficiency—When There Is Too Little of a Good Thing
    Thomas J. Wang · 2017 · JAMA Cardiology
  64. The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers
    Marin Nishimura, Alison M. Brann, Kay‐Won Chang, Alan S. Maisel · 2018 · Current Heart Failure Reports
  65. Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide
    Nirav Patel, Orlando M. Gutiérrez, Garima Arora, George Howard, Virginia J. Howard, Suzanne E. Judd, Sumanth D. Prabhu, Emily B. Levitan, Mary Cushman, Pankaj Kumar Arora · 2019 · International Journal of Cardiology
  66. Body Mass Index and Clinical Outcomes in Asian Patients With Atrial Fibrillation Receiving Oral Anticoagulation
    So‐Ryoung Lee, Eue‐Keun Choi, Jin‐Hyung Jung, Sang Hyun Park, Kyungdo Han, Seil Oh, Gregory Y.H. Lip · 2021 · Stroke
  67. Hazardous alcohol consumption is associated with increased levels of B-type natriuretic peptide: evidence from two population-based studies
    David A. Leon, Владимир Михайлович Школьников, S. A. Borinskaya, Juan Pablo Casas, Alun Evans, Artyom Urievich Gil, Frank Kee, Nikolay Aleksandrovich Kiryanov, Martin McKee, Mark G. O’Doherty et al. · 2013 · European Journal of Epidemiology
  68. Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease
    Karolina Idzikowska, Marzenna Zielińska · 2018 · Journal of International Medical Research
  69. Metabolomic profiling implicates adiponectin as mediator of a favorable lipoprotein profile associated with NT-proBNP
    Annette Masuch, Maik Pietzner, Martin Bahls, Kathrin Budde, Gabi Kastenmüller, Stephanie Zylla, Anna Artati, Jerzy Adamski, Henry Völzke, Marcus Dörr et al. · 2018 · Cardiovascular Diabetology
  70. Protective Effects of a Discontinuous Treatment with Alpha-Lipoic Acid in Obesity-Related Heart Failure with Preserved Ejection Fraction, in Rats
    Cristina Pop, Maria-Georgia Ștefan, Dana Maria Muntean, Laurențiu Stoicescu, Adrian Florin GAL, Béla Kiss, Claudiu Morgovan, Felicia Loghin, Luc Rochette, Benjamin Lauzier et al. · 2020 · Antioxidants
  71. Diagnostic Thresholds for Pre–Diabetes Mellitus and Diabetes Mellitus and Subclinical Cardiac Disease in the General Population: Data From the ACE 1950 Study
    Peder Langeland Myhre, Magnus Nakrem Lyngbakken, Trygve Berge, Ragnhild Røysland, Erika Nerdrum Aagaard, O Pervez, Brede Kvisvik, Jon Brynildsen, Jon Norseth, Arnljot Tveit et al. · 2021 · Journal of the American Heart Association
  72. Emerging therapies: The potential roles SGLT2 inhibitors, GLP1 agonists, and ARNI therapy for ARNI pulmonary hypertension
    Nicholas E. King, Evan L. Brittain · 2022 · Pulmonary Circulation
  73. Acute Heart Failure with Preserved Ejection Fraction: Unique Patient Characteristics and Targets for Therapy
    Kalkidan G. Bishu, Margaret M. Redfield · 2013 · Current Heart Failure Reports
  74. (Pro)Renin receptor mediates obesity-induced antinatriuresis and elevated blood pressure via upregulation of the renal epithelial sodium channel
    Syed Siraj Ahmed Quadri, Silas Allen Culver, Nrupama Ramkumar, Donald E. Kohan, Helmy M. Siragy · 2018 · PLoS ONE
  75. Effect of Nasal Continuous Positive Airway Pressure in Men on Global Left Ventricular Myocardial Performance in Patients With Obstructive Sleep Apnea Syndrome
    Seiji Koga, Satoshi Ikeda, Jungo Urata, Shigeru Kohno · 2008 · The American Journal of Cardiology
  76. Relationship Between Morning Hypertension Identified by Home Blood Pressure Monitoring and Brain Natriuretic Peptide and Estimated Glomerular Filtration Rate: The Japan Morning Surge 1 (JMS‐1) Study
    Joji Ishikawa, Satoshi Hoshide, Seiichi Shibasaki, Yoshio Matsui, Tomoyuki Kabutoya, Kazuo Eguchi, Shizukiyo Ishikawa, Thomas G. Pickering, Kazuyuki Shimada, Kazuomi Kario · 2008 · Journal of Clinical Hypertension
  77. Brain Natriuretic Peptide in Liver Cirrhosis and Fatty Liver: Correlation with Cardiac Performance
    Amna Ahmed Metwaly, Ashraf Abdel Khalik, Fatma Mohammad Nasr, Amal Ismail Sabry, Mohamed Gouda, Mona Mohamed Hassan · 2016 · Electronic physician
  78. Short term variation in NTproBNP after lifestyle intervention in severe obesity
    Debora Fedele, Virginia Bicchiega, Alessandro Collo, Federica Barutta, Erika Pistone, Gabriella Gruden, Graziella Bruno · 2017 · PLoS ONE
  79. Substantial intraindividual variability of BNP concentrations in patients with hypertension
    David Conen, Matthias Emil Pfisterer, B. E. E. Martina · 2006 · Journal of Human Hypertension
  80. Impact of obesity on plasma B-type natriuretic peptide levels in Japanese community-based subjects
    Megumi Koizumi, Hiroyuki Watanabe, Yoshihiro Kaneko, Kenji Iino, Masaru Ishida, Toshimitsu Kosaka, Yutaka Motohashi, Hiroshi Ito · 2011 · Heart and Vessels
  81. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome
    Lauria, Patricia B. M., Del Puerto, Helen L., Reis, Adelina M., Candido, Ana L., Reis, Fernando M. · 2013 · The Journal of Clinical Endocrinology & Metabolism
  82. Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity
    Aneesh Dhore-Patil, Tariq Thannoun, Rohan Samson, Thierry H. Le Jemtel · 2022 · Frontiers in Physiology
  83. B-Type Natriuretic Peptide in Heart Failure
    Mandeep R. Mehra, Alan S. Maisel · 2005 · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
  84. Wpływ BMI, stężenia leptyny i adiponektyny na rokowanie u pacjentów z niedokrwienną kardiomiopatią rozstrzeniową
    Celina Wojciechowska, Wojciech Jacheć, Ewa Barbara Romuk, Ewa Nowalany-Kozielska, Andrzej Robert Tomasik, Lucyna Siemińśka · 2017 · Endokrynologia Polska
  85. Angiotensin II Receptor Blocker Neprilysin Inhibitor (ARNI): New Avenues in Cardiovascular Therapy
    Massimo Volpe, Giuliano Tocci, Allegra Battistoni, Speranza Donatella Rubattu · 2015 · High Blood Pressure & Cardiovascular Prevention
  86. ANP system activity predicts variability of fat mass reduction and insulin sensitivity during weight loss
    Maria Brachs, Susanna Wiegand, Verena Leupelt, Andrea Ernert, Ulrich Kintscher, Reiner Jumpertz von Schwartzenberg, Anne-Marie Decker, Thomas Bobbert, Norbert Hübner, Wei Chen et al. · 2016 · Metabolism
  87. Potent influence of obesity on suppression of plasma B-type natriuretic peptide levels in patients with acute heart failure: An approach using covariance structure analysis
    Koji Kinoshita, Makoto Kawai, Kosuke Minai, Kazuo Ogawa, Yasunori Inoue, Michihiro Yoshimura · 2016 · International Journal of Cardiology
  88. ST2 and Galectin-3: Ready for Prime Time?
    Wouter C. Meijers, A. Rogier van der Velde, Rudolf A. de Boer · 2016 · PubMed Central
  89. The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19
    Alessandro Bellis, Ciro Mauro, Emanuele Barbato, Bruno Trimarco, Carmine Morisco · 2020 · International Journal of Molecular Sciences
  90. Obesity-related hypertension and chronic kidney disease: from evaluation to management
    Mi‐Hyang Jung, Sang‐Hyun Ihm · 2023 · Kidney Research and Clinical Practice
  91. Plasma Midregional Pro-atrial Natriuretic Peptide Is Associated With Blood Pressure Indices and Hypertension Severity in Adults With Hypertension
    M. Khaleghi, Umer Saleem, Nils G. Morgenthaler, S. T. Turner, A. Bergmann, Joachim Struck, Thomas H. Mosley, Iftikhar J. Kullo · 2009 · American Journal of Hypertension
  92. Inverse Association of N-Terminal Pro-B-Type Natriuretic Peptide with Metabolic Syndrome in Patients with Congestive Heart Failure
    Huai-Ren Chang, Jen‐Che Hsieh, Bang‐Gee Hsu, Ling-Yi Wang, Michael Yu‐Chih Chen, Ji‐Hung Wang · 2013 · PLoS ONE
  93. NT-proBNP is associated with fibulin-1 in Africans: The SAfrEIC study
    Ruan Kruger, Rudolph Schutte, Hugo W. Huisman, W. Scott Argraves, Lars Melholt Rasmussen, Michael Hecht Olsen, Aletta Elisabeth Schutte · 2012 · Atherosclerosis
  94. Is There a Role for N-Terminal Probrain-Type Natriuretic Peptide in Determining Volume Status in Haemodialysis Patients?
    Sanjeev Kumar, Maryam Khosravi, Annick Massart, Andrew Davenport · 2013 · Nephron Clinical Practice
  95. Gender-related alterations in plasma adrenomedullin level and its correlation with body weight gain
    Sayaka Kawano, Yukiko Kawagoe, Kenji Kuwasako, Satoshi Shimamoto, Koji Igarashi, Mariko Tokashiki, Kazuo Kitamura, Johji Kato · 2015 · Endocrine Connections
  96. International Society for Heart and Lung Transplantation Developed in Collaboration With the Force on Practice Guidelines: American College of Cardiology Foundation/American Heart Association Task Diagnosis and Management of Heart Failure in Adults: A Report of the 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the
    Warner Stevenson, Clyde W. Yancy, Maria Elisabetta Mancini, Keith Michl, John A. Oates, Peter S. Rahko, Marc A. Silver, Sanjeev A Francis, Théodore G. Ganiats, Mariell L Jessup et al. · 2009
  97. Cardiac Hypertrophy and Brain Natriuretic Peptide Levels in an Ovariectomized Rat Model Fed a High-Fat Diet
    Gleisy Kelly Neves Gonçalves, Thiago Henrique Caldeira de Oliveira, Najara Oliveira Belo · 2017 · Medical science monitor basic research/Medical science monitor. Basic research
  98. 20th Annual Feigenbaum Lecture: Echocardiography for Precision Medicine—Digital Biopsy to Deconstruct Biology
    Sanjiv Jayendra Shah · 2019 · Journal of the American Society of Echocardiography
  99. Association Between Cardiac Natriuretic Peptides and Lipid Profile: a Systematic Review and Meta-Analysis
    Francesco Spannella, Federico Giulietti, Marica Bordicchia, John C. Jr Burnett, Riccardo Sarzani · 2019 · Scientific Reports
  100. Visceral fat is negatively associated with B-type natriuretic peptide levels in patients with advanced type 2 diabetes
    Takako Sugisawa, Ichiro Kishimoto, Yoshihiro Kokubo, Ayako Nagumo, Hisashi Makino, Yoshihiro Miyamoto, Yasunao Yoshimasa · 2010 · Diabetes Research and Clinical Practice